Preclinical News and Research

RSS
SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

SRI to expand current preclinical molecular imaging capabilities with MILabs VECTor+ system

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Oncology drug development services: an interview with Dr. Jean-Pierre Wery, President of Crown Bioscience, Inc.

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Array BioPharma reports net loss of $0.13 per share for first quarter of fiscal 2014

Viropharma announces financial results for third quarter 2013

Viropharma announces financial results for third quarter 2013

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

Mediterranean diet exerts greater cardioprotective effect than low-fat diet, shows study

Researchers identify new drug for treating irritable bowel syndrome with constipation

Researchers identify new drug for treating irritable bowel syndrome with constipation

Middle Peak Medical raises additional $3M in Series A financing

Middle Peak Medical raises additional $3M in Series A financing

Cancer imaging centers receive £35M grant to develop cutting edge imaging technologies

Cancer imaging centers receive £35M grant to develop cutting edge imaging technologies

Neuropsychoanalysis Association to host conference on depression

Neuropsychoanalysis Association to host conference on depression

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Diffregen awarded SBIR Phase 1 grant to advance Angiocidin towards human clinical trials

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Metformin could serve as radiosensitizer to treat patients with stage III non-small cell lung cancer

Tissue-engineered transplants safe and effective in the long term: Study

Tissue-engineered transplants safe and effective in the long term: Study

Promising technique for treating eye disease proves effective in preclinical studies

Promising technique for treating eye disease proves effective in preclinical studies

Nanopharmaceutical drug shows promise for cancers that resist antiangiogenic drugs

Nanopharmaceutical drug shows promise for cancers that resist antiangiogenic drugs

Angiochem initiates ANG1005 Phase 2 study in patients with recurrent high-grade glioma

Angiochem initiates ANG1005 Phase 2 study in patients with recurrent high-grade glioma

Pancreatic cancer patients may benefit from antibody-drug conjugates

Pancreatic cancer patients may benefit from antibody-drug conjugates

Two drug combinations may provide new treatment option for patients with pancreatic cancers

Two drug combinations may provide new treatment option for patients with pancreatic cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.